for people ages 18 years and up (full criteria)
at San Francisco, California and other locations
study started
estimated completion:



The primary purpose of this study is to determine whether the hepatitis C virus continues to remain unable to be detected in subjects who were previously treated with Asunaprevir (BMS-650032) and/or Daclatasvir (BMS-790052) and achieved sustained virologic response.

Official Title

A Long-Term Follow-up Study of Subjects Who Participated in a Clinical Trial in Which Asunaprevir (BMS-650032) and/or Daclatasvir (BMS-790052) Was Administered for the Treatment of Chronic Hepatitis C


Hepatitis C Hepatitis Hepatitis A Hepatitis, Chronic Hepatitis C, Chronic Asunaprevir (BMS-650032) and/or Daclatasvir (BMS-790052)


You can join if…

Open to people ages 18 years and up

  • Signed Written Informed Consent
  • Subjects must have received at least one dose of Asunaprevir and/or Daclatasvir
  • Subjects participating in Daclatasvir and/or Asunaprevir studies (ie, protocol numbers beginning with AI443, AI444 or AI447) may enroll regardless of virologic response
  • Completed the required post-treatment follow-up period in previous study
  • Must enroll in this study within 6 months of completing previous BMS study or within 6 months of protocol availability at the clinical site
  • Men and women, ages 18 and older

You CAN'T join if...

  • Subject must not have been treated with any antiviral or immunomodulatory drug for chronic hepatitis C (CHC) after completion of the previous study during which Asunaprevir and/or Daclatasvir were administered
  • Subject must not be participating in any other trial, excluding non-interventional trials
  • Prisoners or subjects who are involuntarily incarcerated
  • Subjects who are compulsorily detained for treatment of either a psychiatric or physical (eg, infectious disease) illness


  • U.Cal.-San Francisco
    San Francisco California 94143 United States
  • Anthony M. Mills Md Inc
    Los Angeles California 90069 United States
  • Pacific Oaks Medical Group
    Beverly Hills California 90211-2145 United States
  • Peter J Ruane Md Inc
    Los Angeles California 90036 United States
  • Keck Medical Center of USC, HCC 1
    Los Angeles California 90033 United States


in progress, not accepting new patients
Start Date
Completion Date
Bristol-Myers Squibb
FDA Safety Alerts and Recalls
Investigator Inquiry Form
Study Type
Last Updated
December 6, 2017